- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06744478
Assessing the Magnitude of Anisometropia in Patients Wearing Misight 1 Day Contact Lens
December 19, 2024 updated by: Buddhist Tzu Chi General Hospital
The effectiveness of Misight 1 Day Contact Lens in retarding anisometropic progression has not been investigated before.
This study is aimed to elucidate the efficacy of Misight 1 Day Contact Lens for anisometropia control.
Study Overview
Status
Enrolling by invitation
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
50
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Hualien City, Taiwan, 97002
- Shang-Yen WU
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
N/A
Sampling Method
Probability Sample
Study Population
We enroll the clinical patients who was diagnosed with anisometropia (meaning that myopia exceeds 100 degree diopters during the refraction examination, and the difference between the other eye is more than 100 degree diopters).
Age limit was 8 to 23 years old.
The purpose and process were carefully addressed to the subjects and their guardians who signed an informed consent form before commencing this study.
Description
Inclusion Criteria:
- 8-23 years old children diagnosed with anisometropia and are willing to accept MiSight® 1 Day contact lens wearing treatment.
- No congenital eye diseases or eye diseases such as strabismus and amblyopia.
- Those who have been stated to be willing to participate in the program for at least 24 months and accept various evaluations.
Exclusion Criteria:
- Ocular surface disease( dry eye, keratoconus..)
- Allergy to contact lens
- Received eye surgery before
- The cornea is infected (bacterial, fungal or viral infection).
- Strabismus
- Premature birth
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
myopic children
Myopic children use Misight 1 Day Contact Lens every day for myopia and anisometropia control.
|
Misight 1 Day Contact Lens wearing for myopia control
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes of the visual acuity in myopic children with different Misight 1 Day Contact Lens
Time Frame: From the date of starting treatment, the visual acuity was measured 1 week, 1month and every 3 months up to 24 months.
|
The investigators measure the visual acuity of myopic children with different Misight 1 Day Contact Lens.
|
From the date of starting treatment, the visual acuity was measured 1 week, 1month and every 3 months up to 24 months.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes of axial length in myopic children with different Misight 1 Day Contact Lens
Time Frame: From the date of starting treatment, the axial length was measured, then repeat measure were performed every 6 months up to 24 months
|
The investigators measure the axial length(mm) of eyeball of myopic children with different diopter of Misight 1 Day Contact Lens.
|
From the date of starting treatment, the axial length was measured, then repeat measure were performed every 6 months up to 24 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
January 1, 2025
Primary Completion (Estimated)
December 31, 2025
Study Completion (Estimated)
December 31, 2026
Study Registration Dates
First Submitted
December 16, 2024
First Submitted That Met QC Criteria
December 19, 2024
First Posted (Actual)
March 25, 2025
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
December 19, 2024
Last Verified
December 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB113-170-A
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myopia
-
Tianjin Medical University Eye HospitalNot yet recruitingProgressive Myopia | Pediatric Myopia | Orthokeratology-related Myopia Progression
-
Shanghai General Hospital, Shanghai Jiao Tong University...Not yet recruitingMyopia | Myopia, ProgressiveChina
-
SightGlass Vision, Inc.Recruiting
-
University of FaisalabadCompletedRefractive Errors | Myopia | Progressive MyopiaPakistan
-
SightGlass Vision, Inc.RecruitingMyopia | Myopia Progression | Juvenile MyopiaUnited States
-
Shanghai Eye Disease Prevention and Treatment CenterEnrolling by invitationMyopia, Child Myopia ProgressionChina
-
He Eye HospitalNot yet recruiting
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityActive, not recruiting
-
University Eye Hospital, FreiburgActive, not recruiting
-
University of BradfordUniversity of Huddersfield; CooperVision International Limited (CVIL)Enrolling by invitationMyopia, ProgressiveUnited Kingdom
Clinical Trials on Misight 1 Day Contact Lens
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityRecruiting
-
Visioneering Technologies, IncOhio State UniversityActive, not recruitingMyopiaUnited States
-
CooperVision, Inc.Completed
-
Shanghai Eye Disease Prevention and Treatment CenterNot yet recruiting
-
Fitlens Ltd.RSNESSRecruiting
-
Aston UniversityRecruitingMyopia ProgressionNew Zealand
-
CooperVision, Inc.Completed
-
Alcon ResearchAston UniversityCompleted
-
Johnson & Johnson Vision Care, Inc.Completed